Table 1.
Type of nanoparticle | Target | Anticancer agent | Type of cancer | Reference |
---|---|---|---|---|
Liposomes | Nucleolin, CD44 | F3 peptide, γ-secretase inhibitors (GSIs), Tamoxifen, Paclitaxel | Triple negative breast cancer (TNBC) | Parvani et al., 2015 |
Micelles | ALDH1A1, CD44 | Paclitaxel (PTX), anti-CD44 antibodies, Cetuximab (anti-EGFR), phenformin, gemcitabine, thioridazine (THZ), Twist1 siRNA | Breast cancer, lung cancer | Gener et al., 2015; Krishnamurthy et al., 2015b |
Polymeric nanoparticles | ALDH, CD133 | Hedgehog pathway inhibitor (HPI) | Brain tumor | Lim et al., 2011; Chenna et al., 2012 |
Gold nanoparticles | TGF-β, acid-labile hydrazone bond | Doxorubicin | Breast cancer | Sun et al., 2014 |